IRIS
MAZZOLA, ROSARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.822
AS - Asia 1.300
EU - Europa 693
SA - Sud America 392
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.243
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.776
SG - Singapore 755
DE - Germania 467
BR - Brasile 318
VN - Vietnam 186
CN - Cina 150
HK - Hong Kong 84
IT - Italia 47
FR - Francia 35
GB - Regno Unito 31
IN - India 28
MX - Messico 27
AR - Argentina 26
BD - Bangladesh 18
FI - Finlandia 16
IQ - Iraq 15
AT - Austria 14
EC - Ecuador 14
RU - Federazione Russa 13
NL - Olanda 11
ZA - Sudafrica 11
IE - Irlanda 10
UZ - Uzbekistan 10
ID - Indonesia 9
NG - Nigeria 9
UA - Ucraina 9
CO - Colombia 8
CA - Canada 7
PK - Pakistan 7
PL - Polonia 7
SE - Svezia 7
VE - Venezuela 7
PY - Paraguay 6
CL - Cile 5
MA - Marocco 5
PE - Perù 5
AL - Albania 4
LB - Libano 4
NP - Nepal 4
TR - Turchia 4
BB - Barbados 3
BG - Bulgaria 3
ES - Italia 3
GT - Guatemala 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
JM - Giamaica 2
JP - Giappone 2
KE - Kenya 2
LT - Lituania 2
MT - Malta 2
MY - Malesia 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
RO - Romania 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.243
Salva come PNG Salva come JPEG
Città #
Dallas 1.852
Falkenstein 420
Singapore 318
Ashburn 153
San Jose 148
The Dalles 127
Hong Kong 82
Ho Chi Minh City 60
Wilmington 59
Beijing 56
Chandler 55
Hanoi 45
Shanghai 42
New York 26
São Paulo 25
Ann Arbor 23
San Mateo 22
Los Angeles 19
Orem 18
Helsinki 16
Mexico City 15
Naples 15
Belo Horizonte 11
Lawrence 11
Leawood 11
Princeton 11
Santa Clara 11
Boardman 10
Da Nang 10
Dublin 10
Fairfield 10
London 10
Benin City 9
Düsseldorf 9
Frankfurt am Main 9
Tashkent 9
Chennai 8
Nuremberg 8
Amsterdam 7
Johannesburg 7
Rio de Janeiro 7
Salvador 7
Woodbridge 7
Baghdad 6
Milan 6
Montes Claros 6
Portsmouth 6
Brooklyn 5
Curitiba 5
Fortaleza 5
Guarulhos 5
Haiphong 5
Hillsboro 5
Lahore 5
Porto Alegre 5
Warsaw 5
Can Tho 4
Cologno Monzese 4
Dhaka 4
Florence 4
Goiânia 4
Guayaquil 4
Joinville 4
Marília 4
Montreal 4
Paris 4
Quito 4
Vienna 4
Asunción 3
Beirut 3
Boston 3
Bridgetown 3
Chicago 3
Cleveland 3
Denver 3
Erbil 3
Jundiaí 3
La Plata 3
Lauterbourg 3
Manchester 3
Mumbai 3
Muscat 3
Newark 3
Pisa 3
Recife 3
Reston 3
Rondonópolis 3
Santa Fe 3
Santos 3
Secaucus 3
São José dos Campos 3
Taubaté 3
Tirana 3
Ankara 2
Aparecida de Goiânia 2
Assago 2
Belém 2
Bengaluru 2
Betim 2
Bexley 2
Totale 3.994
Salva come PNG Salva come JPEG
Nome #
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 626
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 625
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes 607
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 584
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 97
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 83
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 83
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 81
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 78
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 68
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 67
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 67
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease 66
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 63
METASTASES-DIRECTED STEREOTACTIC RADIOTHERAPY FOR OLIGOMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER: MULTICENTRE SERIES OF 86 PATIENTS/117 LESIONS 60
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes 60
Stereotactic radiosurgery for intracranial metastases: linac-based and gamma-dedicated unit approach. 55
Stereotactic Body Radiation Therapy for thoracic nodes metastases, a multi-institutional experience 55
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time 51
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system 50
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy 49
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy 49
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy 48
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes 47
SBRT FOR LYMPH NODE METASTASES FROM PROSTATE CANCER: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS 47
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 46
SBRT for lymph node metastases from prostate cancer: a multi-institutional retrospective analysis 46
A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations 45
Dose prescription in SBRT for early-stage non-small cell lung cancer: are we all speaking the same language? 44
Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients 44
The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review 43
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer 42
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity 42
Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell Cancer 41
The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence 39
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes 38
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 37
Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy 37
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 37
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer 36
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases 35
What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer? 35
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 35
Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac 35
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients 34
Linac-based versus MR-guided SBRT for localized prostate cancer: a comparative evaluation of acute tolerability 34
Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option? 34
In reply to Simcock et al 33
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer 33
Prostate re-irradiation: current concerns and future perspectives 32
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity 32
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 32
Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques? 31
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology) 31
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging 31
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 30
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases 30
A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study 30
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 29
PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer 29
Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique 28
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 28
Stereotactic radiotherapy for oligometastases in the lymph nodes 28
Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy 28
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 28
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter to the editor 26
The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy 26
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 26
Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO) 24
Prognostic value of two geriatric screening tools in a cohort of older patients with early stage Non-Small Cell Lung Cancer treated with hypofractionated stereotactic radiotherapy 23
The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes 22
Totale 5.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 11 0 8
2021/202252 4 0 0 14 0 1 0 9 3 5 14 2
2022/2023150 23 5 16 18 13 13 0 11 25 14 10 2
2023/202457 3 5 16 1 1 11 2 1 2 1 5 9
2024/2025842 2 13 11 3 2 101 144 64 83 201 94 124
2025/20264.104 237 359 1.613 333 94 124 456 607 143 138 0 0
Totale 5.315